5,635+ MPCVD Systems Deployed Worldwide IGI · GIA · Certified Lab-Grown Diamonds — Shipping Worldwide Anjali LabTech Limited (Formerly Known as Anjali Diamonds Private Limited)
Building the Infrastructure of the Diamond Economy.
Investor Relations

Building the Infrastructure of the Diamond Economy.

A vertically integrated lab-grown diamond technology company.

The Investment Case

 

We are the first and leading vertically integrated Indian player in the lab-grown diamond (“LGD”) industry, with our capabilities stretching across the entire value chain. Our operations include designing, manufacturing and supplying microwave plasma chemical vapour deposition machines (“MPCVD Machines”) to third-parties which are used for growing rough LGDs (“Rough LGDs”). In addition, we install MPCVD Machines in-house to support the captive growing of Rough LGDs, along with processing and selling polished LGDs (“Polished LGDs”) and manufacturing and selling LGD studded jewellery (“LGD Studded Jewellery”). We were one of the leading global manufacturers of MPCVD Machines used
for growing LGDs, with an estimated global market share of 36% in terms of volume. We are also the largest manufacturer of MPCVD machinery for growing LGDs in India.

| | |
Rajnikant M. Radadiya

Rajnikant M. Radadiya

Chairman & Whole-time Director

Sandipbhai Madhubhai Radadiya

Sandipbhai Madhubhai Radadiya

Managing Director

Gopal Chunibhai Radadiya

Gopal Chunibhai Radadiya

Whole-time Director

Kavita Rakesh Shah

Kavita Rakesh Shah

Independent Director

Shailendra Kumar Shukla

Shailendra Kumar Shukla

Independent Director

Sunil Kumar Bansal

Sunil Kumar Bansal

Independent Director

Board Of Directors

Name Designation
Mr. Rajnikant M. Radadiya Chairman & Wholetime Director
Mr. Sandipbhai Madhubhai Radadiya Managing Director
Mr. Gopal Chunibhai Radadiya Wholetime Director
Mr. Sunil Kumar Bansal Independent Director
Mr. Shailendra Kumar Shukla Independent Director
Mrs. Kavita Rakesh Shah Independent Director

Audit Committee

Name Position in Committee Designation
Mrs. Kavita Rakesh Shah Chairperson Independent Director
Mr. Sunil Kumar Bansal Member Independent Director
Mr. Shailendra Kumar Shukla Member Independent Director
Mr. Sandipbhai Madhubhai Radadiya Member Managing Director

Nomination & Remuneration Committee

Name Position in Committee Designation
Mr. Sunil Kumar Bansal Chairperson Independent Director
Mrs. Kavita Rakesh Shah Member Independent Director
Mr. Shailendra Kumar Shukla Member Independent Director

Stakeholders’ Relationship Committee

Name Position in Committee Designation
Mr. Shailendra Kumar Shukla Chairperson Independent Director
Mr. Sandipbhai Madhubhai Radadiya Member Managing Director
Mr. Gopal Chunibhai Radadiya Member Wholetime Director

Corporate Social Responsibility Committee

Name Position in Committee Designation
Mr. Rajnikant M. Radadiya Chairperson Wholetime Director
Mr. Gopal Chunibhai Radadiya Member Wholetime Director
Mrs. Kavita Rakesh Shah Member Independent Director

Disclaimer – Important

Disclaimer

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before

continuing.

The following disclaimer applies to the abridged prospectus (“Abridged Prospectus”) to the updated draft red herring prospectus-I of Anjali Labtech Limited (the “Company”) each September 24, 2026 (the “Updated Draft Red Herring Prospectus-I” or “UDRHP-I”) filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) and hosted on this website in connection with the proposed initial public offering of the equity shares of the Company (the “Offer”). The Company does not accept any responsibility for any contravention of applicable securities laws and regulations by individuals as a result of false information provided by such individuals. You are advised to read the following notice carefully before reading, accessing or making any other use of the Abridged Prospectus and the UDRHP-I. In accessing the Abridged Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time. 

The Abridged Prospectus and UDRHP-I is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Abridged Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. The contents of the Abridged Prospectus is for your information only, and you acknowledge that access to the Abridged Prospectus is intended for use by you only and you agree not to forward the Abridged Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the Abridged Prospectus shall be copied or duplicated in any form by any means or redistributed.

The Abridged Prospectus has been hosted on this website as prescribed under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). Our Company has taken all necessary steps to ensure that the contents of the Abridged Prospectus as appearing on this website are identical to the Abridged Prospectus and UDRHP-I filed with the SEBI. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. The Company, BRLMs and/or their Affiliates are not soliciting any action based on it, and it should not be construed as an offer to sell or the solicitation of any offer to buy or subscribe for any security and should not be construed as such. The Abridged Prospectus does not amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the SEBI ICDR Regulations, and nothing in the Abridged Prospectus constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the syndicate to subscribe for or purchase any of the securities described therein.  

The Abridged Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.

The Equity Shares have not been recommended by any U.S. federal or state securities commission or regulatory authority. Furthermore, the foregoing authorities have not confirmed the accuracy or determined the adequacy of the Updated Draft Red Herring Prospectus-I or approved or disapproved the Equity Shares. Any representation to the contrary is a criminal offence in the United States. In making an investment decision, investors must rely on their own examination of our Company and the terms of the Offer, including the merits and risks involved. 

The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States, and may not be offered or sold within the United States. Accordingly, the Equity Shares are only being offered and sold outside the United States to investors in “offshore transactions” in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. 

The equity shares have not been and will not be registered, listed or otherwise qualified in any other jurisdiction outside India and may not be offered or sold, and Bids may not be made by persons in any such jurisdiction, except in compliance with the applicable laws of such jurisdiction.

Any person into whose possession the Abridged Prospectus and Updated Draft Red Herring Prospectus-I comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its affiliates is soliciting any action based on the Abridged Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Abridged Prospectus and Updated Draft Red Herring Prospectus-I for any investment decision.

Any decision on whether to invest in the equity shares described in the Abridged Prospectus and the Updated Draft Red Herring Prospectus-I may only be made after a red herring prospectus has been filed with the relevant Registrar of Companies and the SEBI and the stock exchanges, and must be made solely on the basis of such red herring prospectus, as there may be material changes in the red herring prospectus compared to the Abridged Prospectus and Updated Draft Red Herring Prospectus-I. Invitations to subscribe to or purchase the equity shares in the Offer will be made only pursuant to the red herring prospectus if the recipient is in India or the preliminary offering memorandum for the Offer, which comprises the red herring prospectus and the preliminary international wrap for the Offer, if the recipient is outside India. No person outside India is eligible to Bid for equity shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which shall contain the selling restrictions for the Offer outside India.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section titled “Risk Factors” of the red herring prospectus, when available.

Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Abridged Prospectus beyond the date of the Abridged Prospectus. The information contained in the Abridged Prospectus may not be updated since its original publication date and may not reflect the latest updates. The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking the Company or any of their affiliates to post any such amendments or supplements on this website.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located and resident in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to subscribe or buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

You are not permitted to view the Abridged Prospectus in this section of the website.

Disclaimer – Important

Disclaimer

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before

continuing.

The following disclaimer applies to the updated draft red herring prospectus of Anjali Labtech Limited (the “Company”) dated September 24, 2026 (the “Updated Draft Red Herring Prospectus-I” or “UDRHP-I”) filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) and hosted on this website in connection with the proposed initial public offering of the equity shares of the Company (the “Offer”). The Company does not accept any responsibility for any contravention of applicable securities laws and regulations by individuals as a result of false information provided by such individuals. You are advised to read the following notice carefully before reading, accessing or making any other use of the Updated Draft Red Herring Prospectus-I. In accessing the Updated Draft Red Herring Prospectus-I, you agree to be bound by the following terms and conditions, including any modifications to them from time to time. 

The Updated Draft Red Herring Prospectus-I is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Updated Draft Red Herring Prospectus-I, is not for publication or distribution, directly or indirectly, in or into the United States. The contents of the Updated Draft Red Herring Prospectus-I is for your information only, and you acknowledge that access to the Updated Draft Red Herring Prospectus-I is intended for use by you only and you agree not to forward the Updated Draft Red Herring Prospectus-I on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the Updated Draft Red Herring Prospectus-I shall be copied or duplicated in any form by any means or redistributed.

The Updated Draft Red Herring Prospectus-I has been hosted on this website as prescribed under Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). Our Company has taken all necessary steps to ensure that the contents of the Updated Draft Red Herring Prospectus-I as appearing on this website are identical to the Updated Draft Red Herring Prospectus-I filed with the SEBI. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. The Company, BRLMs and/or their Affiliates are not soliciting any action based on it, and it should not be construed as an offer to sell or the solicitation of any offer to buy or subscribe for any security and should not be construed as such. The Updated Draft Red Herring Prospectus-I does not amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the SEBI ICDR Regulations, and nothing in the Updated Draft Red Herring Prospectus-I constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the syndicate to subscribe for or purchase any of the securities described therein.  

The Updated Draft Red Herring Prospectus-I does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.

The Equity Shares have not been recommended by any U.S. federal or state securities commission or regulatory authority. Furthermore, the foregoing authorities have not confirmed the accuracy or determined the adequacy of the Updated Draft Red Herring Prospectus-I or approved or disapproved the Equity Shares. Any representation to the contrary is a criminal offence in the United States. In making an investment decision, investors must rely on their own examination of our Company and the terms of the Offer, including the merits and risks involved. 

The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States, and may not be offered or sold within the United States. Accordingly, the Equity Shares are only being offered and sold in “offshore transactions” in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. 

The equity shares have not been and will not be registered, listed or otherwise qualified in any other jurisdiction outside India and may not be offered or sold, and Bids may not be made by persons in any such jurisdiction, except in compliance with the applicable laws of such jurisdiction.

Any person into whose possession the Updated Draft Red Herring Prospectus-I comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its affiliates is soliciting any action based on the Updated Draft Red Herring Prospectus-I, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Updated Draft Red Herring Prospectus-I for any investment decision.

Any decision on whether to invest in the equity shares described in the Updated Draft Red Herring Prospectus-I may only be made after a red herring prospectus has been filed with the relevant Registrar of Companies and the SEBI and the stock exchanges, and must be made solely on the basis of such red herring prospectus, as there may be material changes in the red herring prospectus compared to the Updated Draft Red Herring Prospectus-I. Invitations to subscribe to or purchase the equity shares in the Offer will be made only pursuant to the red herring prospectus if the recipient is in India or the preliminary offering memorandum for the Offer, which comprises the red herring prospectus and the preliminary international wrap for the Offer, if the recipient is outside India. No person outside India is eligible to Bid for equity shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which shall contain the selling restrictions for the Offer outside India.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section titled “Risk Factors” of the red herring prospectus, when available.

Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Updated Draft Red Herring Prospectus-I beyond the date of the Updated Draft Red Herring Prospectus-I. The information contained in the Updated Draft Red Herring Prospectus-I may not be updated since its original publication date and may not reflect the latest updates. The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking the Company or any of their affiliates to post any such amendments or supplements on this website.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access you are located and resident in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to subscribe or buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

You are not permitted to view the UDRHP-I in this section of the website.
Industry Report ↓

Hindi

English

List of Material Creditors as on March 31st, 2026

Name of The Material CreditorsAmount Outstanding (₹ in million)
Perry International Inc.255.82
DSS Diamond52.77
Saumil Diam USA LLC46.25
Keystar Gems Inc41.83
Neuron International38.07
Zen Diamonds Limited35.94
Total470.68
No documents available.
Grievance Reporting: grievance@anjalilabtech.com

Investor Grievance

Mr. Sakhavala Kaushik Parsotambhai

Company Secretary & Compliance Officer

Address :- Anjali House, 2nd & 3rd Floor, Plot No. 210-211,
Opp. Gitanjali Petrol Pump, Varachha Road,
Surat, Gujarat 395006

Contact No :- +91 261 255 4153/54

Email ID :- cs@anjalilabtech.com

MUFG Intime India Private Limited

Registrar and Share Transfer Agent

Address :- C 101, Embassy 247
L.B.S. Marg, Vikhroli (West)
Mumbai, Maharashtra 400083

Contact No :- +91 22 4918 6000